A Qualitative Exploration of Women Newly Infected with HIV
Interviews conducted by Council researchers will inform ongoing work in the creation of integrated service delivery models.
During the Phase 3 clinical trial of the candidate microbicide Carraguard, 151 women in the placebo group and 134 women in the Carraguard group contracted HIV.
From those participants who contracted HIV, a sample of 18 women from the University of Cape Town’s Gugulethu site and 18 women from the University of Limpopo's Shoshanguve site were interviewed to explore:
- the impact of HIV diagnosis on their lives;
- their reproductive health;
- their contraceptive knowledge and history;
- their fertility intentions;
- their pregnancy history (including termination of pregnancy);
- which, if any, health services had been accessed since learning their HIV status;
- their experiences of interpersonal violence; and
- their nutritional needs.
This information will inform ongoing work in the creation of integrated service-delivery models being conducted by Council collaborators from the University of Cape Town.
No publications are listed
Project Stats
Location: South Africa (Gugulethu, Cape Town; Shoshanguve)
Program(s):
HIV and AIDS
Topic(s):
HIV care, support, and treatment
Integrating health services
Duration: 1/2008 - ongoing
Population Council researchers:
Lauren Katzen
Non-Council collaborators:
Diane Cooper (University of Cape Town)
Jane Harries (Women’s Health Research Unit, University of Cape Town)
Get Involved
- Make a contribution to the Population Council
- Honor a loved one with a gift in their name
- Sign up to receive e-mail announcements
Connect
